63 related articles for article (PubMed ID: 15225688)
1. Privileged scaffolds for blocking protein-protein interactions: 1,4-disubstituted naphthalene antagonists of transcription factor complex HOX-PBX/DNA.
Ji T; Lee M; Pruitt SC; Hangauer DG
Bioorg Med Chem Lett; 2004 Aug; 14(15):3875-9. PubMed ID: 15225688
[TBL] [Abstract][Full Text] [Related]
2. NMR studies of the pbx1 TALE homeodomain protein free in solution and bound to DNA: proposal for a mechanism of HoxB1-Pbx1-DNA complex assembly.
Jabet C; Gitti R; Summers MF; Wolberger C
J Mol Biol; 1999 Aug; 291(3):521-30. PubMed ID: 10448033
[TBL] [Abstract][Full Text] [Related]
3. The HoxB1 hexapeptide is a prefolded domain: implications for the Pbx1/Hox interaction.
Slupsky CM; Sykes DB; Gay GL; Sykes BD
Protein Sci; 2001 Jun; 10(6):1244-53. PubMed ID: 11369863
[TBL] [Abstract][Full Text] [Related]
4. Concerted dynamics link allosteric sites in the PBX homeodomain.
Farber PJ; Mittermaier A
J Mol Biol; 2011 Jan; 405(3):819-30. PubMed ID: 21087615
[TBL] [Abstract][Full Text] [Related]
5. Pbx1 is required for Hox D3-mediated angiogenesis.
Charboneau A; East L; Mulholland N; Rohde M; Boudreau N
Angiogenesis; 2005; 8(4):289-96. PubMed ID: 16328158
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the 2.0 A crystal structure of the protein-DNA complex of the human PDEF Ets domain bound to the prostate specific antigen regulatory site.
Wang Y; Feng L; Said M; Balderman S; Fayazi Z; Liu Y; Ghosh D; Gulick AM
Biochemistry; 2005 May; 44(19):7095-106. PubMed ID: 15882048
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of the K50 class homeodomain PITX2 bound to DNA and implications for mutations that cause Rieger syndrome.
Chaney BA; Clark-Baldwin K; Dave V; Ma J; Rance M
Biochemistry; 2005 May; 44(20):7497-511. PubMed ID: 15895993
[TBL] [Abstract][Full Text] [Related]
8. Identification of a new type of PBX1 partner that contains zinc finger motifs and inhibits the binding of HOXA9-PBX1 to DNA.
Laurent A; Bihan R; Deschamps S; Guerrier D; Dupé V; Omilli F; Burel A; Pellerin I
Mech Dev; 2007 May; 124(5):364-76. PubMed ID: 17353115
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cancer cell proliferation by designed peptide amphiphiles.
Aulisa L; Forraz N; McGuckin C; Hartgerink JD
Acta Biomater; 2009 Mar; 5(3):842-53. PubMed ID: 19249722
[TBL] [Abstract][Full Text] [Related]
10. Structure of a HoxB1-Pbx1 heterodimer bound to DNA: role of the hexapeptide and a fourth homeodomain helix in complex formation.
Piper DE; Batchelor AH; Chang CP; Cleary ML; Wolberger C
Cell; 1999 Feb; 96(4):587-97. PubMed ID: 10052460
[TBL] [Abstract][Full Text] [Related]
11. Targeting the oligomerization domain of ETO interferes with RUNX1/ETO oncogenic activity in t(8;21)-positive leukemic cells.
Wichmann C; Chen L; Heinrich M; Baus D; Pfitzner E; Zörnig M; Ottmann OG; Grez M
Cancer Res; 2007 Mar; 67(5):2280-9. PubMed ID: 17332359
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of HOX/PBX dimer formation blocks the in vivo proliferation of melanoma.
Morgan R; Pirard PM; Shears L; Sohal J; Pettengell R; Pandha HS
Cancer Res; 2007 Jun; 67(12):5806-13. PubMed ID: 17575148
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of Hox specificity.
Wilson DS; Desplan C
Nat Struct Biol; 1999 Apr; 6(4):297-300. PubMed ID: 10201389
[No Abstract] [Full Text] [Related]
14. Conformational changes in the PBX homeodomain and C-terminal extension upon binding DNA and HOX-derived YPWM peptides.
Sprules T; Green N; Featherstone M; Gehring K
Biochemistry; 2000 Aug; 39(32):9943-50. PubMed ID: 10933814
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine phosphorylation of adaptor protein 3BP2 induces T cell receptor-mediated activation of transcription factor.
Qu X; Kawauchi-Kamata K; Miah SM; Hatani T; Yamamura H; Sada K
Biochemistry; 2005 Mar; 44(10):3891-8. PubMed ID: 15751964
[TBL] [Abstract][Full Text] [Related]
16. DNA recognition mechanism of the ONECUT homeodomain of transcription factor HNF-6.
Iyaguchi D; Yao M; Watanabe N; Nishihira J; Tanaka I
Structure; 2007 Jan; 15(1):75-83. PubMed ID: 17223534
[TBL] [Abstract][Full Text] [Related]
17. Toward an atomistic model for predicting transcription-factor binding sites.
Endres RG; Schulthess TC; Wingreen NS
Proteins; 2004 Nov; 57(2):262-8. PubMed ID: 15340913
[TBL] [Abstract][Full Text] [Related]
18. The NMR solution structure of a mutant of the Max b/HLH/LZ free of DNA: insights into the specific and reversible DNA binding mechanism of dimeric transcription factors.
Sauvé S; Tremblay L; Lavigne P
J Mol Biol; 2004 Sep; 342(3):813-32. PubMed ID: 15342239
[TBL] [Abstract][Full Text] [Related]
19. HOX cofactors expression and regulation in the human ovary.
Ota T; Asahina H; Park SH; Huang Q; Minegishi T; Auersperg N; Leung PC
Reprod Biol Endocrinol; 2008 Oct; 6():49. PubMed ID: 18973687
[TBL] [Abstract][Full Text] [Related]
20. Structure and properties of a re-engineered homeodomain protein-DNA interface.
Simon MD; Feldman ME; Rauh D; Maris AE; Wemmer DE; Shokat KM
ACS Chem Biol; 2006 Dec; 1(12):755-60. PubMed ID: 17240973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
